PO-1167: Salvage therapies for PSMA PET-positive nodal recurrent prostate cancer. (November 2020) - Schmidt-Hegemann, N.; Eze, C.; Rogowski, P.; Schaefer, C.; Li, M.; Buchner, A.; Fendler, W.P.; Bartenstein, P.; Ganswindt, U.; Stief, C.; Belka, C.; Kretschmer, A.